Cleveland BioLabs, Inc. news

   Watch this stock
Showing stories 11 - 20 of about 80   

Articles published

CBLI 1.60 +0.01 (0.63%)
price chart
Big Gainers In Biotech Today | Cleveland BioLabs (CBLI) | RXi Pharmaceuticals ...
Cleveland BioLabs, Inc. (NASDAQ: CBLI) Cleveland BioLabs is having a great day in the market today after the company announced that it has entered into a securities purchase agreement with David Davidovich.
Cleveland BioLabs: A Reverse Split Low Floater With Catalysts
Cleveland BioLabs (NASDAQ:CBLI) offers another such opportunity for investors who are not faint of heart. To put it simply, I believe the company sports such a tiny valuation that any bit of good news could cause it to run hard.
After-Hours Buzz: Amazon.com (AMZN), Cleveland BioLabs (CBLI), Workday (WDAY)
Shares of Seattle, Washington-based Amazon.com Inc. (AMZN) are up in after-hours trading Tuesday after the e-commerce giant said it is hiring more than 6,000 full-time jobs across its U.S.
Cleveland BioLabs, Inc. Increases 63% on Efficacy Study Results
Cleveland BioLabs, Inc. (NASDAQ: CBLI) increased 63% on today's announcement of strong survival results for its randomized, placebo-controlled efficacy study of CBLB502 in animal primates required by the U.S.
Cleveland BioLabs Provides Update on Pre-EUA Review of Entolimod as Radiation ...
BUFFALO, NY--(Marketwired - Mar 16, 2016) - Cleveland BioLabs, Inc. ( NASDAQ : CBLI) today announced an update on the regulatory review of its pre-Emergency Use Authorization (pre-EUA) submission for entolimod as a radiation countermeasure ...
Cleveland Bio's accelerated regulatory clearance for entolimod delayed ...  Seeking Alpha
Cleveland BioLabs Reports Second Quarter 2016 Financial Results and ...
BUFFALO, NY--(Marketwired - Aug 15, 2016) - Cleveland BioLabs, Inc. ( NASDAQ : CBLI) today reported financial results and development progress for the second quarter ended June 30, 2016.
Cleveland BioLabs' Anti-Radiation Drug Makes It A Tempting Speculative Buy
Cleveland Biolabs, a clinical-stage biotechnology company based out of Buffalo, NY (NASDAQ:CBLI) with subsidiaries in Russia (covered later), has developed an anti-radiation drug CBLB502 (now known as Entolimod) which can be taken 24 hours before ...
Cleveland Biolabs (CBLI), Roswell Park Cancer Institute Announce Award of DoD ...
Cleveland BioLabs, Inc. (NASDAQ: CBLI) and Roswell Park Cancer Institute (RPCI)today announced the award of a three-year, $1.2 million Breast Cancer Research Program Breakthrough Award to Roswell Park from the Department of Defense ...
Cleveland BioLabs, Inc. (CBLI) Updated Broker Price Targets
Market analysts have recently updated their ratings and price targets on shares of Cleveland BioLabs, Inc. (CBLI). The latest reports which are currently in issue on Sunday 13th of November state 0 analysts have a rating of “strong buy”, 0 analysts ...
Cleveland BioLabs and Incuron Announce Growth of Curaxin CBL0137 Patent ...
BUFFALO, NY--(Marketwired - Mar 2, 2015) - Cleveland BioLabs, Inc. ( NASDAQ : CBLI) and Incuron LLC, a joint venture between the CBLI and Bioprocess Capital Ventures, announce the issuance of a composition of matter patent for Curaxin CBL0137 in ...